Necker hospital
Paris, 75015, France
NCT Number: NCT02714933
The aim of this study is to compare a new Magnetic Resonance Imaging (MRI)protocol, including a new MRI sequence for visualization of lung parenchyma, to computed tomography as the gold standard for the evaluation of thoracic region in children.
Looking for future studies?
Notify Me6 year–16 year
All sexes
Interventional
Not applicable
Paris, 75015, France
The potential effects of ionizing radiation are of particular concern in children. Exposure to ionizing radiation of medical origin is responsible for an increased risk of brain tumors and hematopoietic lineage in children. It is therefore necessary to find alternative to the use of irradiating imaging examinations. Currently, computed tomography (CT) is the gold standard in the study of lung diseases and is used in children deepening of standard radiography in acute or chronic situations, sometimes requiring iterative controls. Chest CT delivers a radiation dose equivalent to up to 500 days of natural exposure. Moreover, for the analysis of mediastinal and vascular structures it requires an intravenous injection of iodinated contrast, potentially source of nephrotoxicity and anaphylactic reactions. Recently, new developments in Magnetic Resonance Imaging (MRI) have shown interest in the study of lung diseases when they are responsible for filling of aeric structures (mucoid impaction in cystic fibrosis, alveolar filling in infectious process and tumor) and in the analysis of vascular and mediastinal structures and heart. However, the aerated lung presenting a very low density of protons, and MRI being particularly sensitive to artifacts from cardiac and respiratory movements, sequences currently used in MRI remain insufficient in the analysis of pulmonary structures and pathologic conditions not filling aeric spaces (bronchial, cystic, emphysematous or interstitial diseases). The aim of this study is to test in clinical practice, a new MRI sequence for visualizing lung parenchyma, 3D zero Time Echo (Advanced ZTE) and to propose a protocol combining several MRI sequences without injection as an alternative to chest CT with or without contrast medium injection in childhood.
The proposed hypotheses are :
The principal objective of the study is to evaluate the Advanced ZTE sequence in the visualization of lung parenchyma structures in comparison to CT scan in lung window as gold standard.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluation of the image quality in terms of visualization of anatomical structures of the lung parenchyma in safe zone by a new imaging method of the pulmonary parenchyma by MRI (Advanced ZTE sequence).
Time frame: 3 months
Evaluation MRI sequence Advanced ZTE in terms of image quality and visualization of the pulmonary parenchyma
Time frame: 3 months
Quantitative evaluation for the quality of the image obtained by the Advanced ZTE sequence
Time frame: 3 months
Quantitative evaluation for the quality of the image obtained by the Advanced ZTE sequence
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Assistance Publique - Hôpitaux de Paris
Other
Thoracic Imaging in Children With Neither Irradiation Nor Injection, by a New MRI Protocol Including Advanced Zero Time Echo (ZTE)
Acronym: ImagINI-CHEST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07455552
Disease, Lung Cancer (Diagnosis)
Pusan, South Korea
View Trial DetailsNCT00534690
Lung Diseases, Lung Neoplasms
Pessac, France
View Trial DetailsNCT07103499
Body Weight, Lung Diseases
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT02862418
Lung Diseases, Pulmonary Disease
Cincinnati, Ohio, United States
View Trial Details